Login / Signup

Sex differences in the Norwegian Tenecteplase Trial (NOR-TEST).

Haakon Ihle-HansenElse Chartlotte SandsetHege Ihle-HansenGuri HagbergBente ThommessenOle Morten RønningChristopher Elnan KvistadVojtech NovotnyHalvor NaessUlrike Waje-AndreassenLars ThomassenNicola Logallo
Published in: European journal of neurology (2021)
Women were underrepresented in number in NOR-TEST. The included women had a lower cardiovascular risk factor burden and more severe strokes.
Keyphrases
  • polycystic ovary syndrome
  • risk factors
  • pregnancy outcomes
  • clinical trial
  • study protocol
  • phase iii
  • randomized controlled trial
  • insulin resistance
  • phase ii
  • type diabetes
  • adipose tissue
  • skeletal muscle